Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.
Clinical trial NCT05373355 · COMPLETED
Trial details
- NCT number
- NCT05373355
- Sponsor
- Hangzhou Highlightll Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-10
- Primary completion
- 2023-09-07
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.